In our study, the tended significant increase (p = 0.087) of insulin in the T2D group may be explained by a vaguely ameliorated ability of the pancreas to waken the insulin producing β-cells for tissue action, however without a compensatory decrease of the hyperglucagonemia. This evidence concerns the gene INS and type 2 diabetes mellitus.